Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its who makes tirzepatides for Eli Lilly Q3 earnings later this week. Experts are expecting strong performance driven by the robust sales of Lilly's blockbuster treatments, particularly recent launches. However, there are also concerns about pot… Read More